Press release
Jun 23, 2015

Announcement of New Appointments

Tokyo, Japan – 23 June 2015: Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565) is pleased to announce the following new appointments and changes.

Effective as of 23 June 2015:


Short biographies of newly appointed Executive VPs:

Malcolm Weir, Ph.D (24 October 1958)

  • Sep 1997 Visiting Professor of Biochemistry at Imperial College, London
  • Jan 1999 Head of the Molecular Sciences Division of Glaxo Wellcome Inc. (present Glaxo Smithkline plc.)
  • Jun 2000 CEO, Inpharmatica Ltd. present Galapagos NV)
  • Sep 2004 Council of the UK Biotechnology and Biological Sciences Research Council
  • Nov 2006 Medical Research Council Technology
  • Jul 2007 Founder and CEO, Heptares Therapeutics Ltd. (to present) 
Fiona Marshall, Ph.D (1 October 1964)
  • Sep 1990 Head of Molecular Pharmacology, Division of Glaxo Wellcome Inc. (present Glaxo Smithkline plc.)
  • Mar 2000 Head of Discovery Biology, Europe Millenium Pharmaceuticals Inc (currently part of Takeda Pharmaceutical Company Ltd) 
  • Sep 2002 Visiting Lecturer in Pharmacology University of Cambridge
  • Jul 2007 Founder and CSO, Heptares Therapeutics Ltd. (to present)